Discover

'Barbexaclone' (marketed in Italy as 'Maliasin' by Abbott Laboratories) is a salt compound of phenobarbital and propylhexedrine. It was introduced in 1983. It is reported to be as effective as phenobarbital but better tolerated. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital. It is not available on prescription in the UK or U.S.

Contents

References

References

★ ''The Treatment of Epilepsy 2nd Ed'' by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8